Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study
Nicolas W Shammas,1 Bhaskar Purushottam,2 W John Shammas,1 Lori Christensen,1 Gail Shammas,1 Desyree Weakley,1 Sue Jones-Miller1 On behalf of the JET-RANGER Investigators1Midwest Cardiovascular Research Foundation, Davenport, IA, USA; 2Regional Health CR, Cardiovascular Medicine, Monument Health, Ra...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-08-01
|
| Series: | Vascular Health and Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/jetstream-atherectomy-followed-by-paclitaxel-coated-balloons-versus-ba-peer-reviewed-fulltext-article-VHRM |
| _version_ | 1811345163037966336 |
|---|---|
| author | Shammas NW Purushottam B Shammas WJ Christensen L Shammas G Weakley D Jones-Miller S |
| author_facet | Shammas NW Purushottam B Shammas WJ Christensen L Shammas G Weakley D Jones-Miller S |
| author_sort | Shammas NW |
| collection | DOAJ |
| description | Nicolas W Shammas,1 Bhaskar Purushottam,2 W John Shammas,1 Lori Christensen,1 Gail Shammas,1 Desyree Weakley,1 Sue Jones-Miller1 On behalf of the JET-RANGER Investigators1Midwest Cardiovascular Research Foundation, Davenport, IA, USA; 2Regional Health CR, Cardiovascular Medicine, Monument Health, Rapid City, SD, USACorrespondence: Nicolas W Shammas, Research Director, Midwest Cardiovascular Research Foundation, 630 East 4th Street, Suite A, Davenport, IA, USA, Email shammas@mchsi.comBackground: It is unknown at this time whether Jetstream atherectomy (JET) and paclitaxel-coated balloon (PCB) provides a superior outcome to balloon angioplasty (PTA) followed by PCB in treating femoropopliteal (FP) arterial disease.Methods: The JET-RANGER study was a multicenter (eleven US centers) randomized trial, core lab–adjudicated, designed to demonstrate the superiority of JET + PCB versus PTA + PCB in treating FP arterial disease. The study intended to enroll 255 patients, but was stopped early because of poor enrollment due to COVID-19 and concerns about the association of paclitaxel with mortality. The data are thus considered exploratory. A total of 47 patients (48 lesions) with claudication (80.9%) or rest pain/ulcerations (19.2%) were randomly assigned 2:1 to JET + PCB (n=31) or PTA + PCB (n=16). The In.PACT (Medtronic) and Ranger (Boston Scientific) PCBs were used. Freedom from target-lesion revascularization (TLR) was evaluated at 1 year. Analysis was performed on intention to treat.Results: Mean lesion length was 10.8± 4.3 cm for JET + PCB and 11.2± 7.6 cm for PTA + PCB (P=0.858). There were no other differences in demographic or angiographic variables between the two groups. Procedural success was superior with JET + PCB (87.1%) vs PTA + PCB alone (52.9%; P=0.0147). Overall bailout stenting rate was 17% (0 JET + DCB versus 50% PCB, P< 0.0001). There was no distal embolization requiring treatment. There was no amputation or death in either group. Using KM analysis, the primary end point of freedom from TLR (bailout stent considered a TLR) at 1 year was 100% and 43.8% (P< 0.0001) for JET + PCB versus PTA + PCB, respectively. When bailout stent was not considered a TLR, freedom from TLR was 100% and 93.7%, respectively (P=0.327).Conclusion: A high rate of freedom from TLR was seen in the JET + PCB arm and the PTA + DCB arm at 1-year follow-up, with a significant reduction in bailout stenting following vessel prepping with the Jetstream.Keywords: Jetstream, atherectomy, femoropopliteal, vessel prepping, drug-coated balloons, Ranger, In.PACT, randomized trial, dissections, bailout stenting |
| first_indexed | 2024-04-13T19:58:57Z |
| format | Article |
| id | doaj.art-36784f8aa4924ff4a6e36f9ada144246 |
| institution | Directory Open Access Journal |
| issn | 1178-2048 |
| language | English |
| last_indexed | 2024-04-13T19:58:57Z |
| publishDate | 2022-08-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Vascular Health and Risk Management |
| spelling | doaj.art-36784f8aa4924ff4a6e36f9ada1442462022-12-22T02:32:15ZengDove Medical PressVascular Health and Risk Management1178-20482022-08-01Volume 1860361576979Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER StudyShammas NWPurushottam BShammas WJChristensen LShammas GWeakley DJones-Miller SNicolas W Shammas,1 Bhaskar Purushottam,2 W John Shammas,1 Lori Christensen,1 Gail Shammas,1 Desyree Weakley,1 Sue Jones-Miller1 On behalf of the JET-RANGER Investigators1Midwest Cardiovascular Research Foundation, Davenport, IA, USA; 2Regional Health CR, Cardiovascular Medicine, Monument Health, Rapid City, SD, USACorrespondence: Nicolas W Shammas, Research Director, Midwest Cardiovascular Research Foundation, 630 East 4th Street, Suite A, Davenport, IA, USA, Email shammas@mchsi.comBackground: It is unknown at this time whether Jetstream atherectomy (JET) and paclitaxel-coated balloon (PCB) provides a superior outcome to balloon angioplasty (PTA) followed by PCB in treating femoropopliteal (FP) arterial disease.Methods: The JET-RANGER study was a multicenter (eleven US centers) randomized trial, core lab–adjudicated, designed to demonstrate the superiority of JET + PCB versus PTA + PCB in treating FP arterial disease. The study intended to enroll 255 patients, but was stopped early because of poor enrollment due to COVID-19 and concerns about the association of paclitaxel with mortality. The data are thus considered exploratory. A total of 47 patients (48 lesions) with claudication (80.9%) or rest pain/ulcerations (19.2%) were randomly assigned 2:1 to JET + PCB (n=31) or PTA + PCB (n=16). The In.PACT (Medtronic) and Ranger (Boston Scientific) PCBs were used. Freedom from target-lesion revascularization (TLR) was evaluated at 1 year. Analysis was performed on intention to treat.Results: Mean lesion length was 10.8± 4.3 cm for JET + PCB and 11.2± 7.6 cm for PTA + PCB (P=0.858). There were no other differences in demographic or angiographic variables between the two groups. Procedural success was superior with JET + PCB (87.1%) vs PTA + PCB alone (52.9%; P=0.0147). Overall bailout stenting rate was 17% (0 JET + DCB versus 50% PCB, P< 0.0001). There was no distal embolization requiring treatment. There was no amputation or death in either group. Using KM analysis, the primary end point of freedom from TLR (bailout stent considered a TLR) at 1 year was 100% and 43.8% (P< 0.0001) for JET + PCB versus PTA + PCB, respectively. When bailout stent was not considered a TLR, freedom from TLR was 100% and 93.7%, respectively (P=0.327).Conclusion: A high rate of freedom from TLR was seen in the JET + PCB arm and the PTA + DCB arm at 1-year follow-up, with a significant reduction in bailout stenting following vessel prepping with the Jetstream.Keywords: Jetstream, atherectomy, femoropopliteal, vessel prepping, drug-coated balloons, Ranger, In.PACT, randomized trial, dissections, bailout stentinghttps://www.dovepress.com/jetstream-atherectomy-followed-by-paclitaxel-coated-balloons-versus-ba-peer-reviewed-fulltext-article-VHRMjetstreamatherectomyfemoropoplitealvessel preppingdrug coated balloonsrangerin.pactrandomized trialdissectionsbailout stentingtarget lesion revascularization |
| spellingShingle | Shammas NW Purushottam B Shammas WJ Christensen L Shammas G Weakley D Jones-Miller S Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study Vascular Health and Risk Management jetstream atherectomy femoropopliteal vessel prepping drug coated balloons ranger in.pact randomized trial dissections bailout stenting target lesion revascularization |
| title | Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study |
| title_full | Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study |
| title_fullStr | Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study |
| title_full_unstemmed | Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study |
| title_short | Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study |
| title_sort | jetstream atherectomy followed by paclitaxel coated balloons versus balloon angioplasty followed by paclitaxel coated balloons twelve month exploratory results of the prospective randomized jet ranger study |
| topic | jetstream atherectomy femoropopliteal vessel prepping drug coated balloons ranger in.pact randomized trial dissections bailout stenting target lesion revascularization |
| url | https://www.dovepress.com/jetstream-atherectomy-followed-by-paclitaxel-coated-balloons-versus-ba-peer-reviewed-fulltext-article-VHRM |
| work_keys_str_mv | AT shammasnw jetstreamatherectomyfollowedbypaclitaxelcoatedballoonsversusballoonangioplastyfollowedbypaclitaxelcoatedballoonstwelvemonthexploratoryresultsoftheprospectiverandomizedjetrangerstudy AT purushottamb jetstreamatherectomyfollowedbypaclitaxelcoatedballoonsversusballoonangioplastyfollowedbypaclitaxelcoatedballoonstwelvemonthexploratoryresultsoftheprospectiverandomizedjetrangerstudy AT shammaswj jetstreamatherectomyfollowedbypaclitaxelcoatedballoonsversusballoonangioplastyfollowedbypaclitaxelcoatedballoonstwelvemonthexploratoryresultsoftheprospectiverandomizedjetrangerstudy AT christensenl jetstreamatherectomyfollowedbypaclitaxelcoatedballoonsversusballoonangioplastyfollowedbypaclitaxelcoatedballoonstwelvemonthexploratoryresultsoftheprospectiverandomizedjetrangerstudy AT shammasg jetstreamatherectomyfollowedbypaclitaxelcoatedballoonsversusballoonangioplastyfollowedbypaclitaxelcoatedballoonstwelvemonthexploratoryresultsoftheprospectiverandomizedjetrangerstudy AT weakleyd jetstreamatherectomyfollowedbypaclitaxelcoatedballoonsversusballoonangioplastyfollowedbypaclitaxelcoatedballoonstwelvemonthexploratoryresultsoftheprospectiverandomizedjetrangerstudy AT jonesmillers jetstreamatherectomyfollowedbypaclitaxelcoatedballoonsversusballoonangioplastyfollowedbypaclitaxelcoatedballoonstwelvemonthexploratoryresultsoftheprospectiverandomizedjetrangerstudy |